NewsFDA green-lights second RET inhibitor, this time from Blueprint MedicinesadminSeptember 8, 2020 by adminSeptember 8, 2020015The Food and Drug Administration has approved the second drug that targets a certain genetic abnormality found in small percentages of patients with various solid...
